RGA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RGA is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock is in a constructive uptrend, analysts are mostly positive, options sentiment is mildly bullish, and there are no recent negative news or insider/congress selling signals. Since the user is impatient and does not want to wait for a perfect entry, the current level still looks acceptable for a long-term entry rather than a trade to avoid.
RGA shows a bullish technical setup. The MACD histogram is positive and expanding, the moving averages are aligned bullishly with SMA_5 above SMA_20 above SMA_200, and price is holding above the pivot area. RSI_6 at 75.993 is elevated, which suggests the stock is strong rather than weak, though near-term upside could be somewhat extended. Price closed at 216.74 versus a previous close of 221, with key resistance at 219.137 and 222.707, so the stock is trading near resistance but still within an uptrend. Overall, the trend remains bullish.
Analysts have recently raised price targets multiple times, including Barclays, JPMorgan, and Evercore ISI, while keeping positive ratings. The company appears to have reported a beat versus Piper Sandler's estimates, supported by favorable claims across segments. Technical momentum is strong, and there is no recent adverse news in the last week. Hedge fund and insider activity are neutral, which avoids adding a bearish signal.
There is no fresh news catalyst in the last week, so the stock lacks an immediate event-driven upside trigger. RSI is elevated, which means the stock may be somewhat extended in the short term. Analyst views are not uniformly bullish, as UBS remains Neutral and highlighted limited wiggle-room in the sector. Recent trading data shows no strong support from hedge funds or insiders, and there is no recent congress trading activity to reinforce the bullish case.
No reliable latest-quarter financial snapshot was available in the provided data because of a data error, so I cannot confirm the exact quarterly revenue or earnings figures. However, the analyst notes imply the latest quarter was solid, with a beat driven by favorable claims across segments. That suggests the most recent quarter season was favorable and that operating trends are likely improving rather than deteriorating.
Wall Street is mostly constructive on RGA. Recent target increases from Barclays, JPMorgan, and Evercore ISI point to improving confidence, with multiple firms maintaining Overweight/Outperform ratings and targets in the mid-260s to 270 area. Piper Sandler also maintained a positive rating after noting the company beat estimates. The main bearish counterpoint is UBS, which kept a Neutral rating and highlighted cyclicality and limited flexibility in the North American life insurance group. Overall, the pros view is stronger than the cons view.
